Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Detection of c-myc amplification in formalin-fixed paraffin-embedded tumor tissue by chromogenic in situ hybridization (CISH).

Todorović-Raković N.

Methods Mol Biol. 2013;1012:249-54. doi: 10.1007/978-1-62703-429-6_17.

PMID:
24006070
2.
3.
4.
5.
7.

Chromogenic in situ hybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization.

Mayr D, Heim S, Weyrauch K, Zeindl-Eberhart E, Kunz A, Engel J, Kirchner T.

Histopathology. 2009 Dec;55(6):716-23. doi: 10.1111/j.1365-2559.2009.03427.x. Epub .

PMID:
19922593
8.

Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization.

Lambros MB, Simpson PT, Jones C, Natrajan R, Westbury C, Steele D, Savage K, Mackay A, Schmitt FC, Ashworth A, Reis-Filho JS.

Lab Invest. 2006 Apr;86(4):398-408.

9.

Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).

Kiyose S, Igarashi H, Nagura K, Kamo T, Kawane K, Mori H, Ozawa T, Maeda M, Konno K, Hoshino H, Konno H, Ogura H, Shinmura K, Hattori N, Sugimura H.

Pathol Int. 2012 Nov;62(11):728-34. doi: 10.1111/j.1440-1827.2012.02862.x.

PMID:
23121603
10.
11.

Reliability of chromogenic in situ hybridization for epidermal growth factor receptor gene copy number detection in non-small-cell lung carcinomas: a comparison with fluorescence in situ hybridization study.

Yoo SB, Lee HJ, Park JO, Choe G, Chung DH, Seo JW, Chung JH.

Lung Cancer. 2010 Mar;67(3):301-5. doi: 10.1016/j.lungcan.2009.05.002. Epub 2009 Jun 7.

PMID:
19505745
12.

Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.

Hara T, Ooi A, Kobayashi M, Mai M, Yanagihara K, Nakanishi I.

Lab Invest. 1998 Sep;78(9):1143-53.

PMID:
9759658
13.

[Comparision of HER2/neu oncogene detected by chromogenic in-situ hybridization and immunohistochemistry in breast cancer].

Zhang GH, Shi DR, Liang XM, Hou JH, Kang SY, Zhu WD, Li XB, Shao Y, Chen LR, Zhou Y.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):580-3. Chinese.

PMID:
17134562
14.

Amplification of c-myc oncogene by chromogenic and fluorescence in situ hybridization in archival breast cancer tissue array samples.

Rummukainen JK, Salminen T, Lundin J, Joensuu H, Isola JJ.

Lab Invest. 2001 Nov;81(11):1545-51.

PMID:
11706062
16.

[HER-2 oncogene amplification assessment in invasive breast cancer by dual-color in situ hybridization (dc-CISH): a comparative study with fluorescent in situ hybridization (FISH)].

Akhdar A, Bronsard M, Lemieux R, Geha S.

Ann Pathol. 2011 Dec;31(6):472-9. doi: 10.1016/j.annpat.2011.10.013. Epub 2011 Nov 26. Review. French.

PMID:
22172120
17.

Role of chromogenic in situ hybridization (CISH) in the evaluation of HER2 status in breast carcinoma: comparison with immunohistochemistry and FISH.

Li-Ning-T E, Ronchetti R, Torres-Cabala C, Merino MJ.

Int J Surg Pathol. 2005 Oct;13(4):343-51.

PMID:
16273190
18.
19.

Chromogenic in situ hybridization to detect HER-2/neu gene amplification in histological and ThinPrep-processed breast cancer fine-needle aspirates: a sensitive and practical method in the trastuzumab era.

Vocaturo A, Novelli F, Benevolo M, Piperno G, Marandino F, Cianciulli AM, Merola R, Donnorso RP, Sperduti I, Buglioni S, Mottolese M.

Oncologist. 2006 Sep;11(8):878-86.

20.

Validation and workflow optimization of human epidermal growth factor receptor 2 testing using INFORM HER2 dual-color in situ hybridization.

Lim SJ, Cantillep A, Carpenter PM.

Hum Pathol. 2013 Nov;44(11):2590-6. doi: 10.1016/j.humpath.2013.07.005. Epub 2013 Sep 25.

PMID:
24075600
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk